Subbu Nambi's Stock Ratings

Guggenheim Analyst

Subbu Nambi is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024

Overall Average Return

-1.75%

Smart Score

46.2%

Overall Average Return Percentile

34th

Number of Ratings

17
Buy NowGet Alert
06/28/2024GHBuy Now
Guardant Health
$28.4926.36% → $36UpgradeNeutral → BuyGet Alert
06/27/2024SOPHBuy Now
Sophia Genetics
$4.6229.87% → $6Initiates → BuyGet Alert
06/27/2024NAUTBuy Now
Nautilus Biotechnology
$2.39151.05% → $6Initiates → BuyGet Alert
06/26/2024TXGBuy Now
10x Genomics
$19.45DowngradeBuy → NeutralGet Alert
06/25/2024TXGBuy Now
10x Genomics
$19.45DowngradeBuy → NeutralGet Alert
06/18/2024RGENBuy Now
Repligen
$126.06Initiates → NeutralGet Alert
06/05/2024TWSTBuy Now
Twist Bioscience
$49.287.55% → $53Initiates → BuyGet Alert
04/05/2024GHBuy Now
Guardant Health
$28.49Reiterates → NeutralGet Alert
12/14/2023CSTLBuy Now
Castle Biosciences
$21.7714.84% → $25Initiates → BuyGet Alert
12/14/2023MYGNBuy Now
Myriad Genetics
$24.46-5.97% → $23Initiates → BuyGet Alert
12/14/2023GHBuy Now
Guardant Health
$28.49Initiates → NeutralGet Alert
12/14/2023NTRABuy Now
Natera
$107.70-35% → $70Initiates → BuyGet Alert
12/14/2023EXASBuy Now
Exact Sciences
$42.31112.72% → $90Initiates → BuyGet Alert
12/14/2023PACBBuy Now
Pacific Biosciences
$1.36Initiates → NeutralGet Alert
12/14/2023ILMNBuy Now
Illumina
$104.3848.5% → $155Initiates → BuyGet Alert
12/14/2023AKYABuy Now
Akoya Biosciences
$2.34Initiates → NeutralGet Alert
12/14/2023TXGBuy Now
10x Genomics
$19.45208.48% → $60Initiates → BuyGet Alert